| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/24/2003 | WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | WO2003106685A1 Cell wall mutants for delivery of biologically active compounds |
| 12/24/2003 | WO2003106656A2 Single domain tdf-related compounds and analogs thereof |
| 12/24/2003 | WO2003106648A2 Compositions and methods relating to breast specific genes and proteins |
| 12/24/2003 | WO2003106644A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 12/24/2003 | WO2003106634A2 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | WO2003106622A2 Methods for treatment of acute lymphocytic leukemia |
| 12/24/2003 | WO2003106621A2 Anti-igf-i receptor antibody |
| 12/24/2003 | WO2003106499A1 Antibody and inhibitor and transformation method and transformation kit using the same |
| 12/24/2003 | WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus |
| 12/24/2003 | WO2003105897A1 Combined use of a modulator of cd3 and a glp-1 compound |
| 12/24/2003 | WO2003105896A1 Combined use of a modulator of cd3 and a beta cell resting compound |
| 12/24/2003 | WO2003105895A1 Vaccination with immuno-isolated cells producing an immunomodulator |
| 12/24/2003 | WO2003105892A1 Neuroendocrine marker for cancer and method for producing same |
| 12/24/2003 | WO2003105891A2 Use of hec1 antagonists in the treatment of proliferative disorders and cancer |
| 12/24/2003 | WO2003105890A2 Vaccine composition |
| 12/24/2003 | WO2003105879A1 Compositions and methods for preventing, treating and diagnosing diabetes |
| 12/24/2003 | WO2003105875A1 Immunostimulator having antineoplastic action and method for producing said immunostimulator |
| 12/24/2003 | WO2003105855A1 Mitotic kinesin inhibitors |
| 12/24/2003 | WO2003105761A2 Immunotoxin as a therapeutic agent and uses thereof |
| 12/24/2003 | WO2003105750A2 Antigen-presenting cells for neuroprotection and nerve regeneration |
| 12/24/2003 | WO2003105665A2 Epstein-barr virus-specific immunization |
| 12/24/2003 | WO2003089593A3 Adjuvant enhanced immunotherapy |
| 12/24/2003 | WO2003079020A3 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer |
| 12/24/2003 | WO2003078455A3 Virus like particle from papillomavirus and their use in vaccine |
| 12/24/2003 | WO2003077942A3 Virus-like particles of human papillomavirus |
| 12/24/2003 | WO2003075951A3 Novel application of vaccination against tnf-alpha |
| 12/24/2003 | WO2003075827A3 Use of mycobacterium w in the treatment of asthama(obstructive lung disease) |
| 12/24/2003 | WO2003075824A3 Process of manufacturing pharmaceutical composition useful for management of tuberculosis |
| 12/24/2003 | WO2003073097A9 Methods for isolating ligands e.g. t cell epitopes |
| 12/24/2003 | WO2003072598A3 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases |
| 12/24/2003 | WO2003068925A3 Production of a protein delivery system for in vivo therapeutic treatment |
| 12/24/2003 | WO2003066094A3 Hepatitis b vaccines |
| 12/24/2003 | WO2003064473A3 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 12/24/2003 | WO2003051394A3 Calcium phosphate particles as mucosal adjuvants |
| 12/24/2003 | WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 12/24/2003 | WO2003045429A3 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003007985A3 Capsular polysaccharide solubilisation and combination vaccines |
| 12/24/2003 | WO2003003985A8 Polyvalent conjugate vaccine for cancer |
| 12/24/2003 | WO2003000113A3 Compositions and methods for the diagnosis and treatment of tumor |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002096929A3 Polypeptides reacting with hcv-infected patients' antibodies and uses |
| 12/24/2003 | WO2002096455A3 Use of polyclonal immunoglobulins |
| 12/24/2003 | WO2002094199A3 METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD |
| 12/24/2003 | WO2002092764A3 Transgenic animal model of bone mass modulation |
| 12/24/2003 | WO2002090542A3 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 12/24/2003 | WO2002088375A3 Compositions and methods relating to breast specific genes and proteins |
| 12/24/2003 | WO2002088170A3 Cripto blocking antibodies and uses thereof |
| 12/24/2003 | WO2002057303A3 Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides |
| 12/24/2003 | WO2001052878A8 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
| 12/24/2003 | CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore |
| 12/24/2003 | CN1462804A Filtering out non essential segment in copying adenovirus of birds, and its gene engineering products |
| 12/24/2003 | CN1462636A Vaccine of recombined albumen for preventing and treating infection of human C type hepatitis virus and its usage |
| 12/24/2003 | CN1462635A Microzyme vaccine and bacterin for SARS epidemical tissue and its manufacturing method |
| 12/24/2003 | CA2492685A1 Cell wall mutants for delivery of biologically active compounds |
| 12/24/2003 | CA2489726A1 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | CA2489534A1 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 12/24/2003 | CA2489469A1 Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer |
| 12/24/2003 | CA2489440A1 Anti-igf-i receptor antibody |
| 12/24/2003 | CA2489316A1 Antibody and inhibitor, and transfection method or kit using them |
| 12/24/2003 | CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | CA2489292A1 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | CA2488858A1 Immunotoxin as a therapeutic agent and uses thereof |
| 12/24/2003 | CA2488855A1 Antigen-presenting cells for neuroprotection and nerve regeneration |
| 12/24/2003 | CA2488782A1 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 12/24/2003 | CA2488643A1 Coated particles, methods of making and using |
| 12/23/2003 | US6667344 Formoterol, or a derivative; long term storage stability |
| 12/23/2003 | US6667295 DNA vaccine against feline immunodeficiency virus |
| 12/23/2003 | US6667294 Freeze drying aqueous solution |
| 12/23/2003 | US6667175 Allospecific human suppressor CD8+CD28- T cells. |
| 12/23/2003 | US6667156 Treating nervous system tumors; obtain cells, incubate with modulator, evaluate tumor propagtion |
| 12/23/2003 | US6667151 Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease |
| 12/23/2003 | US6667040 Bovine footrot treatment and prevention |
| 12/23/2003 | US6667038 Isolated peptide comprising specified amino acid sequence |
| 12/23/2003 | US6667035 Isolated polypeptide which specifically binds and neutralizes Clostridium difficile enterotoxin (toxin A) |
| 12/23/2003 | US6667026 Allergic contact dermatitis treatment and composition therefor |
| 12/23/2003 | US6667024 Kit comprising molecule with radioisotope binding site linked to antigen-binding fragment of antibody that specifically binds to tumor associated antigen, and metal chelator and basic amino acid or peptide clearing agents |
| 12/23/2003 | CA2301575C Vectors and methods for immunization or therapeutic protocols |
| 12/21/2003 | CA2391116A1 Propagation of cryptosporidium in cell culture |
| 12/18/2003 | WO2003104466A1 Treatment of vascular dysfunction and alzheimer's disease |
| 12/18/2003 | WO2003104436A2 Cancer-linked gene as target for chemotherapy |
| 12/18/2003 | WO2003104429A2 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 12/18/2003 | WO2003104407A2 T cell receptor cdr3 sequences and methods for detection |
| 12/18/2003 | WO2003104401A2 Cancer-linked gene as target for chemotherapy |
| 12/18/2003 | WO2003104391A2 Antibacterial targets in alloiococcus otitidis |
| 12/18/2003 | WO2003104278A1 Tnf-like protein |
| 12/18/2003 | WO2003104272A1 Immunogenic compositions |
| 12/18/2003 | WO2003104263A2 Cytokines and cytokine receptors with reduced immunogenicity |
| 12/18/2003 | WO2003104262A2 Gp41 peptides and methods based-thereon for inhibiting hiv fusion to target cells |
| 12/18/2003 | WO2003104259A2 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF |
| 12/18/2003 | WO2003103822A2 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 12/18/2003 | WO2003103725A1 Compositions and methods for the diagnosis and treatment of tumor |
| 12/18/2003 | WO2003103712A1 Combinations comprising epothilones and pharmaceutical uses thereof |
| 12/18/2003 | WO2003103711A1 Combinations of anti-tissue factor antibodies and anticoagulant and/or antiplatelet agents |
| 12/18/2003 | WO2003103708A1 BIOFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION |
| 12/18/2003 | WO2003103707A1 New method and composition for producing a cellular allogeneic vaccine |
| 12/18/2003 | WO2003103706A2 Immunogenic compositions |
| 12/18/2003 | WO2003103701A1 Compositions and methods for treating diabetes |
| 12/18/2003 | WO2003103605A2 Flexible vaccine assembly and vaccine delivery platform |